Science Explorer Back to mapMap
Discussion
Company · Gurgaon · India

Sphaera Pharma (India)

sphaerapharma.comROR OpenAlex
Research works
33
▲ 63% vs 2018-21
Citations
104
3.2 per fractional work
Top-10% rate
8.4%
all institutions 10.0%
Open access
11%
world 40%
International
19%
world 18%
Sphaera Pharma (India)

Not ranked overall: Sphaera Pharma (India) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Sphaera Pharma (India) work in?

In all years, 47% of research at Sphaera Pharma (India) is in Social Sciences, 29% in Health Sciences. Its largest fields are Psychology (25%), Medicine (20%), Biochemistry, Genetics and Molecular Biology (10%). It does 1.9× the world's share of Social Sciences.

Social Sciences: 15 fractional works · 46.8% of its workPsychology: 8 fractional works · 25.4% of its workClinical Psychology: 5 fractional works · 14.2% of its workSocial Psychology: 3 fractional works · 8.6% of its workExperimental and Cognitive Psychology: 1 fractional works · 2.5% of its workSocial Sciences: 3 fractional works · 8.1% of its workEducation: 1 fractional works · 3.0% of its workLaw: 0 fractional works · 1.5% of its workSociology and Political Science: 0 fractional works · 1.5% of its workGender Studies: 0 fractional works · 1.0% of its workHealth: 0 fractional works · 1.0% of its workEconomics, Econometrics and Finance: 2 fractional works · 5.7% of its workEconomics and Econometrics: 2 fractional works · 5.3% of its workFinance: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.0% of its workArts and Humanities: 1 fractional works · 4.0% of its workLanguage and Linguistics: 1 fractional works · 2.0% of its workPhilosophy: 1 fractional works · 2.0% of its workBusiness, Management and Accounting: 1 fractional works · 3.6% of its workOrganizational Behavior and Human Resource Management: 1 fractional works · 3.0% of its workManagement of Technology and Innovation: 0 fractional works · 0.5% of its workHealth Sciences: 9 fractional works · 28.5% of its workMedicine: 7 fractional works · 19.8% of its workPublic Health, Environmental and Occupational Health: 3 fractional works · 8.3% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 3.0% of its workSurgery: 1 fractional works · 3.0% of its workOncology: 0 fractional works · 1.4% of its workHematology: 0 fractional works · 1.0% of its workPsychiatry and Mental health: 0 fractional works · 1.0% of its workGenetics: 0 fractional works · 0.5% of its workPhysiology: 0 fractional works · 0.4% of its workRheumatology: 0 fractional works · 0.3% of its workEpidemiology: 0 fractional works · 0.2% of its workHepatology: 0 fractional works · 0.2% of its workPharmacology: 0 fractional works · 0.2% of its workHealth Professions: 3 fractional works · 8.4% of its workGeneral Health Professions: 2 fractional works · 5.1% of its workPharmacy: 1 fractional works · 3.3% of its workDentistry: 0 fractional works · 0.3% of its workOral Surgery: 0 fractional works · 0.3% of its workPhysical Sciences: 4 fractional works · 12.9% of its workChemistry: 3 fractional works · 9.3% of its workOrganic Chemistry: 3 fractional works · 9.0% of its workInorganic Chemistry: 0 fractional works · 0.3% of its workEngineering: 0 fractional works · 1.5% of its workCivil and Structural Engineering: 0 fractional works · 1.5% of its workComputer Science: 0 fractional works · 1.0% of its workInformation Systems: 0 fractional works · 1.0% of its workEnvironmental Science: 0 fractional works · 1.0% of its workGlobal and Planetary Change: 0 fractional works · 1.0% of its workLife Sciences: 4 fractional works · 11.8% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 9.8% of its workMolecular Biology: 3 fractional works · 7.9% of its workCancer Research: 0 fractional works · 1.5% of its workCell Biology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 0 fractional works · 1.0% of its workAquatic Science: 0 fractional works · 1.0% of its workNeuroscience: 0 fractional works · 0.8% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.8% of its workImmunology and Microbiology: 0 fractional works · 0.2% of its workALL ITS WORKSphaera Pharma(India)33fractional works, all years
Life Sciences12%Physical Sciences13%Health Sciences29%Social Sciences47%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 16 fields, with their numbers
    1. Psychology825.4%
    2. Social Sciences38.1%
    3. Economics, Econometrics and Finance25.7%
    4. Arts and Humanities14.0%
    5. Business, Management and Accounting13.6%
    1. Medicine719.8%
    2. Health Professions38.4%
    3. Dentistry00.3%
    1. Chemistry39.3%
    2. Engineering01.5%
    3. Computer Science01.0%
    4. Environmental Science01.0%
    1. Biochemistry, Genetics and Molecular Biology39.8%
    2. Agricultural and Biological Sciences01.0%
    3. Neuroscience00.8%
    4. Immunology and Microbiology00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 6.63× its world share, 0 worksBiochemistry, Geneti…Neuroscience: 10.80× its world share, 0 worksNeuroscienceChemistry: 3.72× its world share, 0 worksChemistryDentistry: 16.06× its world share, 0 worksDentistryMedicine: 1.01× its world share, 0 worksMedicineEconomics, Econometrics and Finance: 6.55× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Dentistry, 16.1×. Every wedge is a field page.

All 6 fields, with their numbers
  1. Dentistry16.06×0 works
  2. Neuroscience10.80×0 works
  3. Biochemistry, Genetics and Molecular Biology6.63×0 works
  4. Economics, Econometrics and Finance6.55×0 works
  5. Chemistry3.72×0 works
  6. Medicine1.01×0 works

Who are the top researchers at Sphaera Pharma (India)?

Ranked on the quality score, Somdutta Sen lead among researchers whose main affiliation is Sphaera Pharma (India).

  1. 1 Somdutta Sen India · #5,190,504 worldwide 446 citations · 28 works
All ranked researchers at Sphaera Pharma (India)

What are the most cited papers from Sphaera Pharma (India)?

The most cited paper from Sphaera Pharma (India) is "Malaria in South Asia: Prevalence and control" (Ashwani Kumar et al., 2012), with 76 citations. Next come "Discovery of Novel and Orally Bioavailable Inhibitors of PI3 Kinase Based on Indazole Substituted Morpholino-Triazines" (37) and "N-Propargylated isatin-Mannich mono- and bis-adducts: Synthesis and preliminary analysis of in vitro activity against Tritrichomonas foetus" (29).

Most cited papers
#PaperReleasedCitations
1 Malaria in South Asia: Prevalence and control Ashwani Kumar et al. · Acta Tropica Open access 9 Jan 2012 76
2 Discovery of Novel and Orally Bioavailable Inhibitors of PI3 Kinase Based on Indazole Substituted Morpholino-Triazines Sundeep Dugar, Frank P. Hollinger, Dinesh Mahajan et al. · ACS Medicinal Chemistry Letters Open access 2 Nov 2015 37
3 N-Propargylated isatin-Mannich mono- and bis-adducts: Synthesis and preliminary analysis of in vitro activity against Tritrichomonas foetus Nisha, Kewal Kumar, Gaurav Bhargava et al. · European Journal of Medicinal Chemistry Open access 18 Jan 2014 29
4 Metal-free diastereoselective synthesis of diaza-bicyclo[3.2.0]heptan-7-one and its transformation to functionalized proline esters Yogesh Kumar, Bilash Kuila, Dinesh Mahajan et al. · Tetrahedron Letters 4 Mar 2014 27
5 Plasma peptidome profiling of acute hepatitis E patients by MALDI-TOF/TOF Shikha Taneja, Imran Ahmad, Somdutta Sen et al. · Proteome Science Open access 4 Feb 2011 25
All 26 most cited papers, with filters and sorting

Which keywords describe research at Sphaera Pharma (India)?

By fractional works in all years, weighted toward what it does more of than the world: Mental Health, Quality of Life, Depression, Psychological Distress, Psychological Resilience, Stress, Coping Strategies and Mental Disorders.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Mental Health5▲ 14×6 topics
  2. Quality of Life3▲ 7.7×6 topics
  3. Depression3▲ 13×3 topics
  4. Psychological Distress2▲ 56×3 topics
  5. Psychological Resilience2▲ 129×2 topics
  6. Stress2▲ 19×2 topics
  7. Coping Strategies2▲ 45×2 topics
  8. Mental Disorders2▲ 73×3 topics
  9. Social Support2▲ 14×4 topics
  10. Adversity2▲ 129×1 topic
  11. Epidemiology2▲ 1.30×4 topics
  12. Positive Emotions2▲ 72×1 topic
  13. Synthesis2▲ 8.7×6 topics
  14. Global Burden2▲ 9.3×3 topics
  15. Globalization2▲ 2.5×2 topics
  16. Help-Seeking Behavior2▲ 113×1 topic
  17. Organizational Behavior2▲ 47×2 topics
  18. Self-Efficacy2▲ 24×3 topics
  19. Stigma2▲ 41×1 topic
  20. Family Constellations1▲ 263×1 topic
  21. Medicinal Chemistry1▲ 10×4 topics
  22. Nursing1▲ 33×3 topics
  23. Psychopathology1▲ 23×2 topics
  24. Therapy1▲ 19×1 topic
  25. Competency-Based Education1▲ 46×1 topic
  26. Job Satisfaction1▲ 14×2 topics
  27. Professional Identity Formation1▲ 66×1 topic
  28. Stress Management1▲ 42×2 topics
  29. Well-being1▲ 14×2 topics
  30. Defensive Medicine1▲ 100×1 topic
  31. Malpractice Risk1▲ 100×1 topic
  32. Economic Growth1▲ 4.1×1 topic
  33. Hypercholesterolemia1▲ 61×1 topic
  34. Islamic Education1▲ 21×1 topic
  35. Job Demands-Resources Model1▲ 70×1 topic
  36. Maternal Health1▲ 23×1 topic
  37. Pedagogy1▲ 8.8×1 topic
  38. Policosanol1▲ 354×1 topic
  39. Stunting1▲ 40×1 topic
  40. Work Engagement1▲ 51×1 topic

Which research topics does Sphaera Pharma (India) publish most on?

By volume in 2022-now: Genetic Neurodegenerative Diseases, Mitochondrial Function and Pathology, Financial Markets and Investment Strategies and Hedgehog Signaling Pathway Studies.

Genetic Neurodegenerativ…0Genetic Neurodegenerative Diseases: 0 fractional worksMitochondrial Function a…0Mitochondrial Function and Pathology: 0 fractional worksFinancial Markets and Investment Strategies: 0 fractional worksHedgehog Signaling Pathway Studies: 0 fractional worksOral and Maxillofacial Pathology: 0 fractional worksCancer Treatment and Pharmacology: 0 fractional worksPain Mechanisms and Treatments: 0 fractional worksBone Tumor Diagnosis and Treatments: 0 fractional worksMarket Dynamics and Volatility: 0 fractional worksSynthesis and pharmacolo…0Synthesis and pharmacology of benzodiazepine derivatives: 0 fractional works
Cellular and Molecular NeuroscienceMolecular BiologyFinanceOral Surgery5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 0 works
  2. 2 Mitochondrial Function and Pathology Molecular Biology 0 works
  3. 3 Financial Markets and Investment Strategies Finance 0 works
  4. 4 Hedgehog Signaling Pathway Studies Molecular Biology 0 works
  5. 5 Oral and Maxillofacial Pathology Oral Surgery 0 works
  6. 6 Cancer Treatment and Pharmacology Oncology 0 works
  7. 7 Pain Mechanisms and Treatments Physiology 0 works
  8. 8 Bone Tumor Diagnosis and Treatments Rheumatology 0 works
  9. 9 Market Dynamics and Volatility Economics and Econometrics 0 works
  10. 10 Synthesis and pharmacology of benzodiazepine derivatives Organic Chemistry 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available10.6%not open89.4%

World: 40% of research is openly available.

with international co-authors19.3%domestic only80.7%

World: 18% is written across borders.

How has Sphaera Pharma (India)'s research output changed?

Output in 2022-2025 was 63% higher than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Sphaera Pharma (India) as a percentage of every work published that year, 0.000020% in 2022.

still counting0.00010%0.00020%Sphaera Pharma (India)0.0000066% in 202520102020

Fractional works of Sphaera Pharma (India) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Gurgaon

All research institutions in Gurgaon

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Sphaera Pharma (India). Posts are plain text and can be reported.